News
Speaking exclusively to Newsweek, parents Edna and Tony shared they will 'gladly' explain to their seven-month-old son the ...
Gay men in Nigeria said that they tested positive for HIV two months after losing access to a US-supplied drug that ...
Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...
Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...
Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...
Newsday Zimbabwe She was speaking in an interview on the sidelines of the ongoing Sadc Joint Meeting of Ministers Responsible for Education in Harare yesterday. THE University of Zimbabwe Clinical ...
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Johannesberg, South Africa | THE INDEPENDENT | Food and Drug Administration (FDA) approval of injectable lenacapavir (LEN) ...
Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results